|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosch FX and de Sanjosé S: Chapter 1:
Human papillomavirus and cervical cancer-burden and assessment of
causality. J Natl Cancer Inst Monogr. 3–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thanagumtorn K: Survival rate of recurrent
cervical carcinoma. J Med Assoc Thai. 95 Suppl 3:S125–S130.
2012.PubMed/NCBI
|
|
4
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Canavan TP and Doshi NR: Cervical cancer.
Am Fam Physician. 61:1369–1376. 2000.PubMed/NCBI
|
|
6
|
Bosch FX, Manos MM, Muñoz N, Sherman M,
Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV:
Prevalence of human papillomavirus in cervical cancer: A worldwide
perspective. International biological study on cervical cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Winkelstein W Jr: Smoking and cervical
cancer-current status: A review. Am J Epidemiol. 131:945–960. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ledwaba T, Dlamini Z, Naicker S and Bhoola
K: Molecular genetics of human cervical cancer: Role of
papillomavirus and the apoptotic cascade. Biol Chem. 385:671–682.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong YF, Cheung TH, Tsao GS, Lo KW, Yim
SF, Wang VW, Heung MM, Chan SC, Chan LK, Ho TW, et al: Genome-wide
gene expression profiling of cervical cancer in Hong Kong women by
oligonucleotide microarray. Int J Cancer. 118:2461–2469. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biewenga P, Buist MR, Moerland PD, Ver
Loren van Themaat E, van Kampen AH, ten Kate FJ and Baas F: Gene
expression in early stage cervical cancer. Gynecol Oncol.
108:520–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berger B, Peng J and Singh M:
Computational solutions for omics data. Nat Rev Genet. 14:333–346.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pappa KI, Polyzos A, Jacob-Hirsch J,
Amariglio N, Vlachos GD, Loutradis D and Anagnou NP: Profiling of
discrete gynecological cancers reveals novel transcriptional
modules and common features shared by other cancer types and
embryonic stem cells. PLoS One. 10:e01422292015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
den Boon JA, Pyeon D, Wang SS, Horswill M,
Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et
al: Molecular transitions from papillomavirus infection to cervical
precancer and cancer: Role of stromal estrogen receptor signaling.
Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kerr MK: Linear models for microarray data
analysis: Hidden similarities and differences. J Comput Biol.
10:891–901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin W, Dong P, Ma C, Mitchelson K, Deng T,
Zhang L, Sun Y, Feng X, Ding Y, Lu X, et al: MicroRNA-133b is a key
promoter of cervical carcinoma development through the activation
of the ERK and AKT1 pathways. Oncogene. 31:4067–4075. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang W, Shu S, Yongmei L, Endong Z, Lirong
Y and Bei S: miR-224-3p inhibits autophagy in cervical cancer cells
by targeting FIP200. Sci Rep. 6:332292016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R,
Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al: miR-506 acts as a
tumor suppressor by directly targeting the hedgehog pathway
transcription factor Gli3 in human cervical cancer. Oncogene.
34:717–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:(Database Issue). D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44:D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kutmon M, Kelder T, Mandaviya P, Evelo CT
and Coort SL: CyTargetLinker: A cytoscape app to integrate
regulatory interactions in network analysis. PLoS One.
8:e821602013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ciriello G, Cerami E, Sander C and Schultz
N: Mutual exclusivity analysis identifies oncogenic network
modules. Genome Res. 22:398–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cancer Genome Atlas Research Network;
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School, . Helen F. Graham Cancer Center &
Research Institute at Christiana Care Health Services, et
al: Integrated genomic and molecular characterization of
cervical cancer. Nature. 543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fabregat A, Sidiropoulos K, Garapati P,
Gillespie M, Hausmann K, Haw R, Jassal B, Jupe S, Korninger F,
McKay S, et al: The Reactome pathway Knowledgebase. Nucleic Acids
Res. 44:D481–D487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Law V, Knox C, Djoumbou Y, Jewison T, Guo
AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, et al:
DrugBank 4.0: Shedding new light on drug metabolism. Nucleic Acids
Res. 42:(Database Issue). D1091–D1097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang W, Soares J, Greninger P, Edelman EJ,
Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et
al: Genomics of drug sensitivity in cancer (GDSC): A resource for
therapeutic biomarker discovery in cancer cells. Nucleic Acids Res.
41:(Database Issue). D955–D961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mi H, Huang X, Muruganujan A, Tang H,
Mills C, Kang D and Thomas PD: PANTHER version 11: Expanded
annotation data from Gene Ontology and Reactome pathways, and data
analysis tool enhancements. Nucleic Acids Res. 45:D183–D189. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aguirre-Gamboa R, Gomez-Rueda H,
Martínez-Ledesma E, Martínez-Torteya A, Chacolla-Huaringa R,
Rodriguez-Barrientos A, Tamez-Peña JG and Treviño V: SurvExpress:
An online biomarker validation tool and database for cancer gene
expression data using survival analysis. PLoS One. 8:e742502013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hadley W: Ggplot2: Elegrant graphics for
data analysis. Springer; Switzerland: 2016
|
|
36
|
Xiao S, Zhou Y, Yi W, Luo G, Jiang B, Tian
Q, Li Y and Xue M: Fra-1 is downregulated in cervical cancer
tissues and promotes cervical cancer cell apoptosis by p53
signaling pathway in vitro. Int J Oncol. 46:1677–1684. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han X, Tang J, Wang J, Ren F, Zheng J,
Gragg M, Kiser P, Park PS, Palczewski K, Yao X and Zhang Y:
Conformational change of human checkpoint kinase 1 (Chk1) induced
by DNA damage. J Biol Chem. 291:12951–12959. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao Q, Huang X, Tang D, Cao Y, Chen G, Lu
Y, Zhuang L, Wang S, Xu G, Zhou J and Ma D: Influence of chk1 and
plk1 silencing on radiation- or cisplatin-induced cytotoxicity in
human malignant cells. Apoptosis. 11:1789–1800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mazumder Indra D, Mitra S, Roy A, Mondal
RK, Basu PS, Roychoudhury S, Chakravarty R and Panda CK:
Alterations of ATM and CADM1 in chromosomal 11q22.3–23.2 region are
associated with the development of invasive cervical carcinoma. Hum
Genet. 130:735–748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hsieh WT, Lin HY, Chen JH, Lin WC, Kuo YH,
Wood WG, Lu HF and Chung JG: Latex of Euphorbia antiquorum-induced
S-phase arrest via active ATM kinase and MAPK pathways in human
cervical cancer HeLa cells. Environ Toxicol. 30:1205–1215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Robertson KD and Jones PA: Tissue-specific
alternative splicing in the human INK4a/ARF cell cycle regulatory
locus. Oncogene. 18:3810–3820. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wijetunga NA, Belbin TJ, Burk RD, Whitney
K, Abadi M, Greally JM, Einstein MH and Schlecht NF: Novel
epigenetic changes in CDKN2A are associated with progression of
cervical intraepithelial neoplasia. Gynecol Oncol. 142:566–573.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB
and Herman JG: In situ detection of the
hypermethylation-induced inactivation of the p16 gene as an early
event in oncogenesis. Proc Natl Acad Sci USA. 96:12754–12759. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Irie N, Weinberger L, Tang WW, Kobayashi
T, Viukov S, Manor YS, Dietmann S, Hanna JH and Surani MA: SOX17 is
a critical specifier of human primordial germ cell fate. Cell.
160:253–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
van der Meide WF, Snellenberg S, Meijer
CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, Snijders PJ and
Steenbergen RD: Promoter methylation analysis of WNT/β-catenin
signaling pathway regulators to detect adenocarcinoma or its
precursor lesion of the cervix. Gynecol Oncol. 123:116–122. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen YC, Huang RL, Huang YK, Liao YP, Su
PH, Wang HC, Chang CC, Lin YW, Yu MH, Chu TY and Lai HC:
Methylomics analysis identifies epigenetically silenced genes and
implies an activation of β-catenin signaling in cervical cancer.
Int J Cancer. 135:117–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
